by JAMEL VALENCIA | The National Desk
Thu, June 6th 2024 at 6:25 PM
Updated Thu, June 6th 2024 at 6:26 PM
LOS ANGELES, CALIFORNIA – JUNE 22: In this photo illustration, packages of Juul e-cigarettes sit on a table on June 22, 2022 in Los Angeles, California. The Food and Drug Administration (FDA) is reportedly preparing to order Juul Labs Inc. to remove its e-cigarette products from the U.S. market. (Photo Illustration by Mario Tama/Getty Images)
WASHINGTON (TND) — The U.S. Food and Drug Administration rescinded its marketing ban on vaping products made by Juul Labs.
The government agency announced Thursday that it was lifting it marketing denial order it had placed on the e-cigarette maker.
Juul’s products can be sold while the FDA conducts a “scientific review.”
A news release noted that there wasn’t “sufficient evidence regarding the toxicological profile of the products to demonstrate that the marketing of the products met the public health standard required by law.”
The FDA pointed out that rescinding the marketing ban, “does not indicate whether the applications are likely to be authorized or denied.”
In June 2022, Juul Labs was denied to market its products like devices, tobacco and menthol-flavored pods.
According to Juul, its pods contain 5% or 3% nicotine concentration.
It’s unknown when a final decision on whether or not Juul Labs products can ultimately stay on the market.
Juul responded Thursday saying it looks forward to working again with the FDA on the scientific review.
We remain confident in the quality and substance of our applications and believe that a full review of the science and evidence will demonstrate that our products meet the statutory standard of being appropriate for the protection of public health.
The American Lung Association was “deeply troubled” by the FDA’s announcement, according to ABC News. The agency was asked by the association to deny all Juul products and cited the company’s role in the “youth e-cigarette epidemic from 2017-2019.”
0 Comments